Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$25.61 - $35.1 $1,126 - $1,544
-44 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$34.54 - $47.25 $59,097 - $80,844
-1,711 Reduced 97.49%
44 $2,000
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $59,097 - $80,844
1,711 Added 3888.64%
1,755 $44,000
Q2 2020

Aug 04, 2020

SELL
$46.85 - $61.05 $10,447 - $13,614
-223 Reduced 83.52%
44 $3,000
Q1 2020

Apr 27, 2020

BUY
$41.6 - $63.4 $2,288 - $3,487
55 Added 25.94%
267 $13,000
Q4 2019

Feb 05, 2020

SELL
$53.85 - $65.27 $2,907 - $3,524
-54 Reduced 20.3%
212 $13,000
Q2 2019

Jul 30, 2019

BUY
$62.09 - $86.14 $3,663 - $5,082
59 Added 28.5%
266 $17,000
Q1 2019

Apr 18, 2019

BUY
$52.92 - $81.17 $1,693 - $2,597
32 Added 18.29%
207 $16,000
Q4 2018

Mar 26, 2019

BUY
$43.37 - $59.54 $7,589 - $10,419
175 New
175 $9,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.43B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Liberty Wealth Management LLC Portfolio

Follow Liberty Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty Wealth Management LLC with notifications on news.